Of note, tumor tissues of the highest CHE dosage group (ESC + CHE 321 mg/kg group) had a significantly lower ki67 immunostaining (P < 0.05) than those of the ESC + DOX group (Fig. 7 A and B). This evidence concerns the gene MKI67 and neoplasm.